RV-C15 replicates in ciliated epithelial cells leading to decreased CDHR3 levels. by Talita B. Gagliardi (6791720)

Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean CRT (μm ± standard deviation) significantly decreased from 504.7 ± 118.2 μm preoperatively to 302.5 ± 60.5 at 1 month, 307.5 ± 64.4 at 3 months, 286.8 ± 49.0 at 6 months, 305.3 ± 79.5 at 12 months, 288.8 ± 79.1 at 24 months, and 295.2 ± 87.4 at 36 months (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Knockdown of ABCG2 in PANC-1 clone cells increases 5-ALA staining. by Noriko Kawai (6694010)

Total soluble protein contents of ovaries from queens sampled at different seasonal time points. by Mark J. Carroll (3605582)

Expression of ABC transporter genes. by Noriko Kawai (6694010)

Fig 5 - by Thomas Jacquet (9960275)

Total lipid contents of fat bodies from queens sampled at different seasonal time points. by Mark J. Carroll (3605582)

Subsystems and pathways enriched or decreased within fecal microbiome from Control and ATB groups before induction of colitis. by Peris Mumbi Munyaka (830957)

Mean best-corrected visual acuity (BCVA) ± standard error of the means (± SEM) before and at 1, 2, 3, 4, 5 years and final visit following the LMT surgery. by Hisaaki Oshima (4042748)

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, CRT (μm ± standard deviation) significantly decreased from 546.1 ± 117.0 μm preoperatively to 317.1 ± 46.9, 317.8 ± 55.6, 290.8 ± 33.5, 342.9 ± 82.2, 333.0 ± 84.2, and 349.8 ± 76.9 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Average predicted probabilities for top 5 publications & average initial placement rankings, controlling for ability, as a function of Alma mater ranking. by Sergey V. Popov (6719075)

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

The T37A substitution in M1 protein is associated with increased production of H9N2 virus in human A549 cells. by Chenxi Wang (284364)

Reducing the catalyst concentration decreases elasticity of elastomers. by Viktor Heinrichs (5071448)

Critical temperature <em>T_c</em> for different values of the anisotropy parameter <em>a</em> for the π-flux cubic lattice model at half-filling (from top to bottom, <em>... by G Mazzucchi (557358)

“…The reason for such a choice is that the π-flux cubic lattice displays Dirac points and that decreasing the hopping coefficient in a spatial direction (say, <em>t_z</em>), these Dirac points are unaltered: it is then possible to study the 3D–2D interpolation towards the π-flux square lattice. …”

Data_Sheet_1_Electroconvulsive therapy triggers a reversible decrease in brain N-acetylaspartate.pdf by Vera J. Erchinger (16239980)

“…We hypothesized that disruption of neuronal networks could trigger biochemical alterations leading to a temporary decrease in N-acetylaspartate (tNAA, considered a marker of neuronal integrity), while choline (a membrane component), myo-Inositol (mI, astroglia marker), and glutamate/glutamine (Glx, excitatory neurotransmitter) were postulated to increase. …”

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on early cytokine response after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Risk Assessment and the Impact of Point of Contact Intervention Following Emergency Department Presentation with a Fall by Kristie J. Harper (3903760)

Cofactors required for Vpu activities. by Charlotte A. Stoneham (10819125)